- Home
- IBG vs BJDX Comparison
IBG vs BJDX Comparison
Compare IBG & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | BJDX |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Australia | United States |
| Employees | 9 | N/A |
| Industry | Beverages (Production/Distribution) | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IBG | BJDX |
|---|---|---|
| Price | $0.74 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.0K | 28.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $249,040.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.63 |
| 52 Week High | $6.50 | $4.17 |
Technical Indicators
Market Signals| Indicator | IBG | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 31.09 | 56.40 |
| Support Level | $0.69 | $1.72 |
| Resistance Level | $1.31 | $2.10 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 16.11 | 62.50 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.